Table 4. Patterns of treatment of patients with prostate cancer.
| Variable | Value |
|---|---|
| No. of patients | 41 |
| Age (y) | 69.6±8.3 |
| Serum PSA (ng/mL) | 8.1±4.8 |
| Prostate volume in TRUS (mL) | 37.7±17.3 |
| Biopsy Gleason sum | |
| 6 | 11 (26.8) |
| 7 | 10 (24.3) |
| 8 | 11 (26.8) |
| 9 | 5 (12.2) |
| 10 | 4 (9.8) |
| Clinical stage | |
| T1 | 38 (92.7) |
| T2 | 2 (4.9) |
| T3 | 1 (2.4) |
| Treatment methods | |
| Prostatectomy | 12 (29.3) |
| Hormone therapy | 25 (60.9) |
| Conservative management | 4 (9.8) |
| Cause of death | |
| Primary cancer | 9 (21.9) |
| Prostate cancer | 1 (2.4) |
| Other | 1 (2.4) |
Values are presented as mean±standard deviation or number (%).
PSA, prostate-specific antigen; TRUS, transrectal ultrasonography.